An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer

Long-term inflammatory stimulation is considered one of the most important causes of colorectal cancer. Diphenyleneiodonium (DPI), an NADPH oxidase inhibitor, can inhibit a variety of inflammatory responses. However, the systemic toxicity of DPI limits its clinical application. Whether DPI can inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuai, Yue, Liu, Hao, Liu, Dongyu, Liu, Yunlong, Sun, Ye, Xie, Jiansheng, Sun, Jiachun, Fang, Yong, Pan, Hongming, Han, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295061/
https://www.ncbi.nlm.nih.gov/pubmed/32550901
http://dx.doi.org/10.7150/thno.43938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295061/
https://www.ncbi.nlm.nih.gov/pubmed/32550901
http://dx.doi.org/10.7150/thno.43938

Ejemplares similares